Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis

Neuromuscular Disorders

Volumn 16, Issue 2, 2006, Pages 137-143

  Tüzün, Erdem ^a   Saini, Shamsher S ^a   Ghosh, Sidharth ^a   Rowin, Julie ^b   Meriggioli, Matthew N ^b   Christadoss, Premkumar ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anti C1q antibody; Autoimmunity; Circulating immune complexes; Experimental autoimmune myasthenia gravis; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MOUSE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; COMPLEMENT C1; COMPLEMENT C1Q; COMPLEMENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; NEUROMUSCULAR JUNCTION; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 31944438299     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2005.11.005     Document Type: Article

References (10)

1. E. Tuzun, B.G. Scott, and H. Yang Circulating immune complexes augment severity of antibody-mediated myasthenia gravis in hypogammaglobulinemic RIIIS/J mice J Immunol 172 2004 5743 5752
2. E. Tuzun, B.G. Scott, E. Goluszko, S. Higgs, and P. Christadoss Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis J Immunol 171 2003 3847 3854
3. P. Christadoss C5 gene influences the development of murine myasthenia gravis J Immunol 140 1988 2589 2592
4. N. Marto, M.L. Bertolaccini, E. Calabuig, G.R. Hughes, and M.A. Khamashta Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus Ann Rheum Dis 64 2005 444 448
5. J.D. Reveille Predictive value of autoantibodies for activity of systemic lupus erythematosus Lupus 13 2004 290 297
6. S. Yoshinoya, Y. Mizoguchi, S. Aotsuka, R. Yokohari, K. Nishioka, and T. Miyamoto Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA J Clin Lab Immunol 38 1992 161 173
7. J.J. Wisnieski, and S.M. Jones Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus J Immunol 148 1992 1396 1403
8. L.A. Trouw, M.A. Seelen, and R. Visseren Anti-C1q autoantibodies in murine lupus nephritis Clin Exp Immunol 135 2004 41 48
9. L.A. Trouw, T.W. Groeneveld, and M.A. Seelen Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes J Clin Invest 114 2004 679 688
10. V.M. Holers Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus J Clin Invest 114 2004 616 619